A1222 - Steviol glycosides from Yarrowia lipolytica

This application seeks approval to permit the use of a steviol glycoside mixture, Rebaudioside MD, that is produced by fermentation from a genetically modified Yarrowia lipolytica (Y. lipolytica), expressing steviol glycoside biosynthesis pathway genes, as an intense sweetener.

Approval report - 27 September 2021 (PDF 1.18 mb) (Word 141 kb)


Call for Submissions - 11 June 2021 (PDF 259 kb) (Word 135 kb)

Supporting document 1 - Safety Assessment (PDF 242 kb) (Word 111 kb)

Submission's (zip 1.38 mb)

Administrative Assessment - 9 February 2021 (PDF 96.1 kb) (Word.70.1 kb)

Executive Summary (PDF 131 kb)

Application(PDF 665 kb)


Applications published on our website may contain material owned by a third party. If you wish to re-use third party material, you may need to seek permission from the copyright owner.